SKIN CANCER SCREENING CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

The clinic’s name is not disclosed. We are a specialized dermatology clinic launching in 2026 in a high-risk U.S. market that focuses exclusively on early detection and prevention of skin cancer. Operating in the medical diagnostics and preventive care sector, our primary services are diagnostic skin cancer screenings and longitudinal patient monitoring using advanced imaging and analysis technology. Our team is composed of board-certified specialists and technicians trained in the latest imaging techniques, and the facility is designed for efficiency and patient comfort to provide a streamlined path to better skin health. One-line: A 2026 launch of a focused skin-cancer screening clinic in a high-risk U.S. market.

We deliver care through scheduled diagnostic screenings, image-based monitoring programs, and coordinated follow-ups to track lesions over time. What sets us apart is exclusive focus on diagnostics and longitudinal monitoring, advanced medical technology beyond general dermatology practices, and a team credentialed in specialized imaging. Our target market is adults in the high-risk region who need regular screenings and long-term lesion surveillance. Short-term goals are to open in 2026 and reach steady weekly screening volume; long-term goals are to sustain longitudinal care programs and reduce progression to late-stage skin cancer in our patient panel. One-line: Focused diagnostics, continuous monitoring, and measurable reduction in late-stage diagnoses.

Problem

Skin cancer is the most prevalent cancer in the United States, with millions of new cases diagnosed annually. Patients face long waits—often months—for specialized screenings, while general dermatology clinics prioritize cosmetic and high-volume cases, leaving few dedicated slots for preventative screening.

The result is delayed detection, more invasive and costly treatments, higher mortality risk, fragmented care, and increased patient anxiety. A dedicated clinic launching in 2026 in a high-risk U.S. market focused exclusively on diagnostic screenings and longitudinal monitoring is necessary to close this gap and provide timely, specialist-led preventive care.

Solution

Patients face long waits and limited access to focused skin-cancer screening because many dermatology practices prioritize cosmetic work. We close that gap with a dedicated clinical service delivering prompt, specialized skin examinations and advanced diagnostic screening to high-risk and symptomatic patients, improving early detection and reducing diagnostic delay.

Core features include same-to-days appointments, advanced imaging and dermoscopy, structured long-term monitoring plans, and coordinated specialist referrals—delivering faster, more accurate diagnoses by eliminating cosmetic services and concentrating resources on preventative and diagnostic care.

Mission Statement

Our mission is to save lives by detecting and preventing skin cancer early through accessible, expert-led screenings. We commit to using the most advanced diagnostic technology to deliver precision and peace of mind for patients and clinicians. We focus on serving high-risk individuals and the medical community with compassionate, patient-centered care that prioritizes long-term health over cosmetic trends.

Key Success Factors

Critical capabilities and milestones that will determine the clinic’s operational and financial success.

• Establish a robust referral network with local primary care physicians and specialists.
• Maintain high clinical utilization through efficient scheduling and a strong digital marketing presence.
• Recruit and retain top-tier clinicians including dermatologists and mid-level providers.
• Integrate and maintain advanced diagnostic technology to sustain clinical leadership.
• Achieve 25-month breakeven via disciplined financial management and cost control.

Financial Summary

Quick financial snapshot for the Executive Summary: the clinic scales from $1.269M revenue in Year 1 to $3.928M in Year 3 and reaches breakeven in January 2028 (25 months).

The launch requires $970,000 in capex for medical tech and renovations; the model shows minimum cash of -$376,000 (Dec-27), breakeven in Jan-28 (25 months) and payback in 47 months.

Financial outlook: revenue and EBITDA grow materially by Year 3, supporting a low single-digit IRR and modest ROE for investors.

Funding Requirements

The clinic requires approximately $1,400,000 to launch and reach breakeven; projected revenue grows from $1,269,000 in Year 1 to $7,367,000 in Year 5, with operational breakeven in January 2028 and total capital expenditure for the 2026 launch estimated at $970,000.